Howard Andrews, Ph.D.

Director, Trials Operation and Management Unit

Associate Clinical Professor of Biostatistics
College of Physicians and Surgeons, Columbia University 

Research Scientist V
New York State Psychiatric Institute

Selected Publications

Brickman AM, Schupf N, Manly JJ, Luchsinger JA, Andrews H, Tang MX, Reitz C, Small SA, Mayeux R, DeCarli C, Brown TR. 2008. Brain morphology in older African Americans, Caribbean Hispanics, and whites from northern Manhattan. Arch Neurol 65(8):1053-61.

Gordon PH, Cheung YK, Levin B, Andrews H, Doorish C, Macarthur RB, Montes J, Bednarz K, Florence J, Rowin J, Boylan K, Mozaffar T, Tandan R, Mitsumoto H, Kelvin EA, Chapin J, Bedlack R, Rivner M, McCluskey LF, Pestronk A, Graves M, Sorenson EJ, Barohn RJ, Belsh JM, Lou JS, Levine T, Saperstein D, Miller RG, Scelsa SN. 2008. Combination drug selection trial study group: a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Sclerosis 9(4):212-22.

Benn EK, Hauser WA, Shih T, Leary L, Bagiella E, Dayan P, Green R, Andrews H, Thurman DJ, Hesdorffer DC. 2008. Estimating the incidence of first unprovoked seizure and newly diagnosed epilepsy in the low-income urban community of Northern Manhattan, New York City. Epilepsia. 49(8):1431-9. Epub 2008 Mar 11.

Devanand DP, Tabert MH, Cuasay K, Manly JJ, Schupf N, Brickman AM, Andrews H, Brown TR, Decarli C, Mayeux R. 2008. Olfactory identification deficits and MCI in a multi-ethnic elderly community sample. Neurobiol Aging Oct 27.

Gordon PH, Cheung YK, Levin B, Andrews H, Mitsumoto H. 2008. Response to commentary on a novel, efficient, randomized selection trial comparing combinations of drug therapy for ALS. Amyotroph Lateral Scler Nov 4:1.